AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2015
May 23, 2015
34983_dirs_2015-05-22_ce2b1680-d7fd-4dec-8d70-263f6438d047.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEXARIA CORP. (LXRP)
CIK: 0001348362
Period of Report: 2015-03-26
Reporting Person: DOCHERTY JOHN MARTIN (President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-15 | Common Shares | P | 130000 | $0.1 | Acquired | 130000 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-15 | Warrants | $0.25 | P | 130000 | Acquired | 2017-05-15 | Common Shares (130000) | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $0.1 | 2020-03-26 | Common Shares (500000) | 500000 | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19